Knight Therapeutics Inc T.GUD

Whats Next - Drug Wise after Ibsrela

[schocor]

I might not have said it explicitly, but I am a fan of Ibsarela and GUD's partnership. I also have the luxury or not caring what they paid for it and really hope to sidestep that whole part of the conversation. The primary use of this drug looks profitable to GUD from where I sit and the possibility of a secondary use is appealing. SO - what are every bodies thoughts on the next drug or drugs to be approved at GUD and does anybody have any guesses on when that might be. Thanks in advance for valuable, forward looking commentary.

[MrMugsy]

That's a good question ... Here are a couple things I know: 1.  TULSA-PRO may be coming to Sunnybrook in the future.  Not only did I hear it from a Sunnybrook Doctor (via a YouTube discussion about prostate cancer) but I have also heard it from GUD recently.  Reimbursement and MRI availability are hurdles to future deployment in Canada.   From Profound - I am

[Benedict16th]

GBT was suppose to be the big deal turning needle for GUD. It did but down not up with lots of losses and no new dugs, the rest of the drugs are small potatos and will not make a big difference and at this pace it will take 100 Years. Now GUD MNGT are keeping the cash so that GUD does not become a penney stock. They simply had no clue and just did not know how to manage and invest 800 M.  It

[Spirou25]

Hello MrMugsy, When you say the list is outdated. Does that mean they have other drugs in the pipeline that we might not be aware of ? Thanks

[MrMugsy]

I will have to look - as I'm not sure when the list was last updated. I know it hasn't been updated in a while (e.g. TULSA PRO still shows as waiting on submission but Heath Canada has already approved it). The list hasn't been updated in a long time and needs to be cleaned up. Also, if there are any drugs still coming to market in LATAM, I'm no aware of them. Would need to dig